ADC Therapeutics News

RBC Capital Maintains ADC Therapeutics(ADCT.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsNov 8 07:31 ET

ADC Therapeutics Analyst Ratings

BenzingaNov 8 07:08 ET

Stephens Initiates ADC Therapeutics(ADCT.US) With Buy Rating, Announces Target Price $6

Moomoo NewsNov 7 17:31 ET

ADC Therapeutics Initiated With an Overweight at Stephens on Zynlonta Potential

TipRanksNov 7 16:43 ET

ADC Therapeutics Price Target Maintained With a $8.00/Share by RBC Capital

Dow JonesAug 7 11:43 ET

ADC Therapeutics Analyst Ratings

BenzingaAug 7 11:32 ET

RBC Capital Reaffirms Their Buy Rating on ADC Therapeutics (ADCT)

TipRanksAug 7 07:28 ET

Capital One Financial Maintains ADC Therapeutics(ADCT.US) With Buy Rating, Cuts Target Price to $9

Moomoo NewsAug 6 21:31 ET

Buy Rating Upheld for ADC Therapeutics SA Amidst Strong Financials and Promising Oncology Pipeline

TipRanksAug 6 20:37 ET

ADC Therapeutics Analyst Ratings

BenzingaMay 30 08:57 ET

Buy Rating Affirmed for ADC Therapeutics on Strong Zynlonta Clinical Data and Strategic Growth Outlook

TipRanksMay 7 08:21 ET

ADC Therapeutics Analyst Ratings

BenzingaMay 7 06:31 ET

ADC Therapeutics Analyst Ratings

BenzingaApr 15 07:52 ET

Buy Rating Affirmed for ADC Therapeutics on Strong Preclinical Data and Promising Trial Progress

TipRanksApr 15 06:25 ET

Analysts Conflicted on These Healthcare Names: ADC Therapeutics (ADCT), Adial Pharmaceuticals (ADIL) and Steris (STE)

TipRanksApr 11 11:35 ET

ADC Therapeutics Analyst Ratings

BenzingaApr 5 09:57 ET

Analysts' Top Healthcare Picks: ADC Therapeutics (ADCT), TFF Pharmaceuticals (TFFP)

TipRanksApr 4 13:25 ET

ADC Therapeutics Analyst Ratings

BenzingaMar 28 06:47 ET

Analysts Conflicted on These Healthcare Names: Veradigm (OtherMDRX), ADC Therapeutics (ADCT) and Sangamo Biosciences (SGMO)

TipRanksMar 15 21:55 ET

Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT) and Cresco Labs (OtherCRLBF)

TipRanksMar 13 13:35 ET